153 related articles for article (PubMed ID: 34189756)
1. Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination.
Ramessur R; Saffar N; Czako B; Agarwal A; Batta K
Clin Exp Dermatol; 2021 Dec; 46(8):1610-1612. PubMed ID: 34189756
[No Abstract] [Full Text] [Related]
2. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
David R; Hanna P; Lee K; Ritchie A
Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433
[No Abstract] [Full Text] [Related]
3. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia.
Chen VM; Curnow JL; Tran HA; Choi PY
Med J Aust; 2021 Sep; 215(6):245-249.e1. PubMed ID: 34490632
[No Abstract] [Full Text] [Related]
4. Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections.
Marples RR; Rebora A; Kligman AM
Arch Dermatol; 1973 Aug; 108(2):237-40. PubMed ID: 4579498
[No Abstract] [Full Text] [Related]
5. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
6. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Wantavornprasert K; Noppakun N; Klaewsongkram J; Rerknimitr P
Clin Exp Dermatol; 2022 Feb; 47(2):428-432. PubMed ID: 34482558
[No Abstract] [Full Text] [Related]
7. Isolated thrombosis after COVID-19 vaccination: case series.
Al-Ahmad M; Al Rasheed M; Altourah L; Rodriguez-Bouza T; Shalaby N
Int J Hematol; 2022 Feb; 115(2):153-157. PubMed ID: 34993889
[TBL] [Abstract][Full Text] [Related]
8. [Aphthous stomatitis. What do physicians advise?].
Herrmann D
MMW Fortschr Med; 2002 Feb; 144(9):11. PubMed ID: 11921643
[No Abstract] [Full Text] [Related]
9. Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?
Ungari M; Pezzarossa E
Am J Dermatopathol; 2022 Jan; 44(1):80-82. PubMed ID: 34726187
[No Abstract] [Full Text] [Related]
10. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
Hasegawa T; Yazaki Y
Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
[No Abstract] [Full Text] [Related]
11. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
Lim PN; Wylie G
Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
[TBL] [Abstract][Full Text] [Related]
12. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.
Elamin S; Hinds F; Tolland J
Clin Exp Dermatol; 2022 Jan; 47(1):153-155. PubMed ID: 34398977
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 timeline of events.
Webster P
Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
[No Abstract] [Full Text] [Related]
14. Report of two cases of minimal change disease following vaccination for COVID -19.
Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
[No Abstract] [Full Text] [Related]
15. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Morales-Garcia P; Mesa-Aguado F; Bascones-Martinez A; Bravo M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):688-92. PubMed ID: 12789149
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a new halcinonide-antifungal combination.
Barba-Rubio J
Curr Ther Res Clin Exp; 1976 Nov; 20(5):655-60. PubMed ID: 136333
[No Abstract] [Full Text] [Related]
17. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
Guan CY; Tsai SH; Fan JS; Lin YK; Kao CC
Am J Emerg Med; 2022 Jan; 51():427.e3-427.e4. PubMed ID: 34274191
[TBL] [Abstract][Full Text] [Related]
18. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
[TBL] [Abstract][Full Text] [Related]
19. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
[No Abstract] [Full Text] [Related]
20. Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach.
Rahaman MM; Sarkar MMH; Rahman MS; Islam MR; Islam I; Saha O; Akter S; Banu TA; Jahan I; Habib MA; Goswami B; Bari L; Malek MA; Khan MS
J Med Virol; 2022 Apr; 94(4):1670-1688. PubMed ID: 34939673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
